Guidelines for Evaluating an Essential Drugs Programme
(64 pages) Ver el documento en el formato PDF
Índice de contenido
Ver el documentoINTRODUCTION
Ver el documentoPROCEDURES FOR EVALUATION OF AN ACTION PROGRAMME ON ESSENTIAL DRUGS (APED)
Ver el documentoEXECUTIVE SUMMARY: OVERALL CONCLUSIONS AND RECOMMENDATIONS
Ver el documento1. SUMMARY BACKGROUND INFORMATION ON COUNTRY AND HEALTH CARE SYSTEM1
Ver el documento2. BRIEF DESCRIPTION OF THE GENERAL FEATURES OF THE APED PROGRAMME
Ver el documento3. ECONOMIC AND SOCIOECONOMIC ASPECTS OF THE APED PROGRAMME
Abrir esta carpeta y ver su contenido4. ANALYSIS OF EFFICIENCY
Abrir esta carpeta y ver su contenido5. ASSESSMENT OF EFFECTIVENESS
Abrir esta carpeta y ver su contenido6. MANAGING THE ESSENTIAL DRUG PROGRAMME
Abrir esta carpeta y ver su contenido7. ASSESSMENT OF INPUTS OF THE GOVERNMENT AND DONORS
Abrir esta carpeta y ver su contenido8. PLANNING FOR THE FUTURE
Ver el documento9. REFERENCES
Abrir esta carpeta y ver su contenidoMANUAL FOR CONDUCTING AN EVALUATION OF AIM ACTION PROGRAMME ON ESSENTIAL DRUGS (APED)
 

EXECUTIVE SUMMARY: OVERALL CONCLUSIONS AND RECOMMENDATIONS

The most important phase of the evaluation exercise consists of stating overall conclusions and recommendations.

a) Overall conclusions

On the basis of the analysis of components and functions (see sections 4 and 5), a concise narrative evaluation statement shall be provided.

b) Recommendations

Most recommendations will be the result of the above-mentioned analysis. The recommendations must include information on who will be responsible for the necessary action or approval and when it is required.

 

Ir a la sección anterior Ir a la siguiente sección
 

Última actualización: le 3 mayo 2013